Evaluation of Left Ventricular Autothreshold, Phase Two
| Status: | Archived |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | May 2011 |
This study will collect data, from an implanted Cardiac Resynchronization
Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart
failure devices.
ELEVATE 2.0 is an acute, prospective, multi-center, feasibility study randomized within
patient test sequence and pulse width, designed to characterize the performance of the Left
Ventricular Auto Threshold (LVAT) feature.
We found this trial at
1
site
Click here to add this to my saved trials
